Goldenseal and Simvastatin
Supplement–drug interaction evidence from the TruthStack database.
| Severity | HIGH |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | PHARMACODYNAMIC RISK |
| Mechanism | PHARMACOKINETIC |
| Last Reviewed | 2026-02-15 |
Summary
Goldenseal CYP3A4 inhibition increases simvastatin levels. Rhabdomyolysis risk. Combination is flagged in literature or use non-CYP3A4 statin. Discuss with your prescriber or pharmacist.
API Reference
GET https://api.truthstack.co/v1/check?c1=goldenseal&c2=simvastatin
Open, unauthenticated. Returns JSON. Developer documentation
Related Interactions
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.